NeoGenomics, Inc.
NEOFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
661
Cost of Revenue
370
Gross Profit
290
Gross Margin
43.9%
Operating Income
-92
Operating Margin
-13.9%
Net Income
-79
Net Margin
-11.9%
EPS (Basic)
$-3.10
EPS (Diluted)
$-3.10
EBITDA
-2
EBITDA Margin
-0.2%
2023
12/31/2023
Revenue
592
Cost of Revenue
347
Gross Profit
245
Gross Margin
41.3%
Operating Income
-108
Operating Margin
-18.2%
Net Income
-88
Net Margin
-14.9%
EPS (Basic)
$-3.50
EPS (Diluted)
$-3.50
EBITDA
-18
EBITDA Margin
-3.0%
2022
12/31/2022
Revenue
510
Cost of Revenue
322
Gross Profit
188
Gross Margin
36.9%
Operating Income
-158
Operating Margin
-30.9%
Net Income
-144
Net Margin
-28.3%
EPS (Basic)
$-5.80
EPS (Diluted)
$-5.80
EBITDA
-82
EBITDA Margin
-16.2%
2021
12/31/2021
Revenue
484
Cost of Revenue
297
Gross Profit
187
Gross Margin
38.6%
Operating Income
-119
Operating Margin
-24.5%
Net Income
-8
Net Margin
-1.7%
EPS (Basic)
$-0.35
EPS (Diluted)
$-0.35
EBITDA
-65
EBITDA Margin
-13.5%
2020
12/31/2020
Revenue
444
Cost of Revenue
259
Gross Profit
186
Gross Margin
41.8%
Operating Income
-14
Operating Margin
-3.1%
Net Income
4
Net Margin
0.9%
EPS (Basic)
$0.19
EPS (Diluted)
$0.19
EBITDA
35
EBITDA Margin
7.8%